NuVasive Inc

NuVasive — Merger or Acquisition (January 2016)

12 slides from NuVasive's merger presentation, Jan 5, 2016

  1. Slide 1: NuVasive, Inc. Acquisition of Ellipse Technologies, Inc.

    NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 Exhibit 99.2

  2. Slide 2: Safe Harbor Statements

    Safe Harbor Statements NuVasive, Inc. (“NuVasive,” “NUVA” or the “Company”) cautions you that statements included in this presentation that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not

  3. Slide 3: Ellipse at a Glance

    Ellipse at a Glance Committed to innovation, passion for improved clinical outcomes Business Description Privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity Developer and marketer of disruptive, magnetically adjustable implant syst

  4. Slide 4: Strategic rationale for the acquisition

    Accelerates NuVasive’s transition from spine implant company to spine solutions company, offering broad range of integrated capabilities to deliver improved clinical and economic outcomes for patients and hospitals Complementary offerings to NuVasive that further diversify revenue mix and present ne

  5. Slide 5: Transaction Overview

    Transaction Overview $380mm acquisition with $30mm potential milestone payment, financed with cash on hand Revenue Accelerates revenue growth toward the high single-digit range New applications of existing technology represent further upside opportunity Synergies Near-term annual operating cost syne

  6. Slide 6: Value Proposition

    Value Proposition Ellipse’s technology rapidly becoming standard of care in spine and orthopedics Builds on NuVasive’s reputation as leading technology provider and innovator for integrated spine procedure solutions Integrate highly regarded, differentiated and disruptive magnetic growing rod techno

  7. Slide 7: Ellipse's Attractive Growth Profile

    Ellipse’s Attractive Growth Profile U.S. dollar amounts in millions, except surgeon count Revenues by Region Revenues by Product U.S. Surgeon Adoption >425% CAGR 2016 revenues expected to be ~$60 million on pro forma basis; Go forward gross margins to range in low to mid ~70%

  8. Slide 8: New, Large Market Opportunities

    New, Large Market Opportunities $1.2 billion* current addressable market opportunity Highly scalable business with growth prospects both geographically and in addressable segments Proprietary Technology Non-invasively adjustable implants expected to have significant economic benefits over current im

  9. Slide 9: MAGEC

    MAGEC Eliminates lengthening surgeries Fewer complications More frequent adjustment to accommodate growth Improved patient outcomes and quality of life ~$570mm* global market opportunity Rapid training cycle: same initial procedure as traditional rods Single implant: fewer trays, less instrumentatio

  10. Slide 10: PRECICE Revolutionizes Approach

    Proprietary PRECICE LLD system developed using MAGEC technology to treat limb length discrepancies Non-invasive, adjustable intramedullary nail coupled with ERC Designed to internally lengthen the long bones of leg with precision and control, and without need for external fixation Innovative techniq

  11. Slide 11: Summary

    Reinforces focus on transformative spine solutions to improve patient outcomes Extends position as global spine leader with comprehensive approach to fast-growing complex deformity market Provides new innovation platforms to strategically address broader spine and niche orthopedic applications Immed

  12. Slide 12: Questions & Answers

    Questions & Answers J fo

Nuvasive — Merger or Acquisition (January 2016) on 6ix